Q2 2018 EPS Estimates for AmerisourceBergen Corp. Boosted by Analyst (ABC)
AmerisourceBergen Corp. (NYSE:ABC) – Stock analysts at Jefferies Group increased their Q2 2018 earnings per share estimates for shares of AmerisourceBergen in a report issued on Wednesday. Jefferies Group analyst B. Tanquilut now anticipates that the company will post earnings per share of $1.82 for the quarter, up from their prior estimate of $1.66. Jefferies Group currently has a “Hold” rating and a $95.00 price target on the stock. Jefferies Group also issued estimates for AmerisourceBergen’s FY2018 earnings at $6.55 EPS and FY2019 earnings at $7.41 EPS.
ABC has been the topic of several other reports. Zacks Investment Research cut AmerisourceBergen from a “buy” rating to a “hold” rating in a research note on Wednesday, January 31st. Needham & Company LLC reduced their price objective on AmerisourceBergen from $117.00 to $113.00 and set a “buy” rating on the stock in a research note on Thursday, February 8th. Goldman Sachs Group upgraded AmerisourceBergen from a “neutral” rating to a “buy” rating in a research note on Friday, December 15th. Leerink Swann set a $105.00 price objective on AmerisourceBergen and gave the company a “buy” rating in a research note on Tuesday, January 2nd. Finally, Robert W. Baird set a $99.00 price objective on AmerisourceBergen and gave the company a “buy” rating in a research note on Friday, December 1st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $101.17.
AmerisourceBergen (NYSE:ABC) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.35 by $0.20. The business had revenue of $40.47 billion for the quarter, compared to analysts’ expectations of $40.42 billion. AmerisourceBergen had a return on equity of 53.65% and a net margin of 0.66%. The company’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period last year, the firm earned $1.36 earnings per share.
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 5th. Shareholders of record on Tuesday, February 20th will be paid a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date is Friday, February 16th. AmerisourceBergen’s dividend payout ratio is presently 34.47%.
In other AmerisourceBergen news, CFO Tim G. Guttman sold 11,600 shares of the firm’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $85.73, for a total value of $994,468.00. Following the sale, the chief financial officer now directly owns 56,436 shares in the company, valued at $4,838,258.28. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Lazarus Krikorian sold 16,427 shares of the firm’s stock in a transaction on Thursday, November 30th. The shares were sold at an average price of $84.86, for a total value of $1,393,995.22. Following the completion of the sale, the senior vice president now owns 23,360 shares in the company, valued at $1,982,329.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 203,077 shares of company stock worth $18,288,730. 27.30% of the stock is owned by insiders.
Hedge funds have recently modified their holdings of the business. Vantage Investment Advisors LLC purchased a new position in shares of AmerisourceBergen during the fourth quarter worth about $156,000. IFG Advisory LLC purchased a new position in shares of AmerisourceBergen during the fourth quarter worth about $678,000. Intl Fcstone Inc. purchased a new position in shares of AmerisourceBergen during the second quarter worth about $201,000. TRUE Private Wealth Advisors purchased a new position in shares of AmerisourceBergen during the fourth quarter worth about $203,000. Finally, IBM Retirement Fund purchased a new position in shares of AmerisourceBergen during the fourth quarter worth about $216,000. 66.84% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2018/02/13/q2-2018-eps-estimates-for-amerisourcebergen-corp-boosted-by-analyst-abc.html.
AmerisourceBergen Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.